VanEck Biotech ETF
BBH
BBH
59 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $151M → $123M (-$28.1M)
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
59
Holding in Top 10
–
Calls
$5.92M
Puts
$2.91M
Top Buyers
| 1 | +$3.99M | |
| 2 | +$1.04M | |
| 3 | +$883K | |
| 4 |
NES
New England Securities
New York
|
+$673K |
| 5 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
+$641K |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$5.09M | |
| 3 | -$4.78M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.88M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.64M |